Kisqali Femara Co-Pack Interactions
There are 767 drugs known to interact with Kisqali Femara Co-Pack (letrozole/ribociclib), along with 8 disease interactions, and 3 alcohol/food interactions. Of the total drug interactions, 331 are major, 419 are moderate, and 17 are minor.
- View all 767 medications that may interact with Kisqali Femara Co-Pack
- View Kisqali Femara Co-Pack alcohol/food interactions (3)
- View Kisqali Femara Co-Pack disease interactions (8)
Most frequently checked interactions
View interaction reports for Kisqali Femara Co-Pack (letrozole / ribociclib) and the medicines listed below.
- acetaminophen / hydrocodone
- acetazolamide
- Activase (alteplase)
- Adriamycin (doxorubicin)
- alendronate
- Aleve (naproxen)
- alprazolam
- amoxicillin / clavulanate
- anastrozole
- atropine
- baclofen
- Bactroban (mupirocin topical)
- Benadryl (diphenhydramine)
- biotin
- calcium citrate
- calcium / vitamin d
- capecitabine
- cefdinir
- cephalexin
- Cinvanti (aprepitant)
- cisplatin
- Citracal Slow Release 1200 (calcium / vitamin d)
- Eliquis (apixaban)
- gabapentin
- omeprazole
- ondansetron
- promethazine
- venlafaxine
- Vitamin B12 (cyanocobalamin)
- Vitamin D3 (cholecalciferol)
Kisqali Femara Co-Pack alcohol/food interactions
There are 3 alcohol/food interactions with Kisqali Femara Co-Pack (letrozole / ribociclib).
Kisqali Femara Co-Pack disease interactions
There are 8 disease interactions with Kisqali Femara Co-Pack (letrozole / ribociclib) which include:
- liver disease
- cholesterol
- osteoporosis
- cutaneous toxicity
- hepatic impairment
- lung toxicity
- QT prolongation
- renal impairment
Report options
More about Kisqali Femara Co-Pack (letrozole / ribociclib)
- Kisqali Femara Co-Pack consumer information
- Compare alternatives
- Pricing & coupons
- Side effects
- Dosage information
- During pregnancy
- Drug class: antineoplastic combinations
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.